Video content above is prompted by the following: NCCN Guideline Updates on Molecular Testing BRCA testing serves 3 critical functions in ovarian cancer management: Informs treatment decisions ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...

AbbVie's Elahere has been shown to reduce the risk of death in patients with folate receptor-alpha (FRα) positive, platinum-resistant ovarian cancer by a third, reinforcing its blockbuster ...

She was diagnosed with stage 4 sacrococcygeal cancer. According to the Nationwide Children’s Hospital online, sacrococcygeal teratoma (SCT), is a tumor that forms on a fetus’s tailbone.

Sclerosing stromal tumor of the ovary in a 4-year-old girl with characteristics of an ovarian signet-ring stromal tumor.